Drug Profile
Research programme: beta-lactamase inhibitors - AnorMED
Latest Information Update: 23 Jul 2002
Price :
$50
*
At a glance
- Originator AnorMED
- Class
- Mechanism of Action Beta lactamase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 23 Jul 2002 Discontinued - Preclinical for Bacterial infections in Canada (unspecified route)
- 07 Aug 2000 Preclinical development for Bacterial infections in Canada (Unknown route)